Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04323137 · ClinicalTrials.gov registry record · NA
Encouraging Flu Vaccination Among High-Risk Patients Identified by ML
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 117,649
- Enrollment target
NCT04323137: Completed NA study, sponsored by Geisinger Clinic.
NCT04323137 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 117,649 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (8292% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04323137, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 117,649 participants
- Enrollment target
Study Summary
The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu vaccination rates of informing health-system patients who are identified by an ML analysis of EHR data to be at high risk for flu complications that they are at high risk with either (a) no additional explanation, (b) an explanation that this determination comes from an analysis of their medical records, and (c) the additional explanation that an AI or ML algorithm made this determination. 2. Evaluate the effects of the same three interventions on diagnoses of flu in the same patients.
Primary Outcome
Patient received a flu vaccination
Interventions
- BEHAVIORAL Risk reduction
- BEHAVIORAL Medical records-based recommendation
- BEHAVIORAL Algorithm-based recommendation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117,649 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-09-21 |
| Phase | NA |
What the finished NCT04323137 record still lists
NCT04323137 is an interventional study that assigns participants to a tested intervention. Its 117,649 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (8292% higher).
The record links to 0 conditions, and to 3 interventions - of which Risk reduction is the first listed.
NCT04323137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04323137 about?
NCT04323137 is a clinical study titled "Encouraging Flu Vaccination Among High-Risk Patients Identified by ML". The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu va...
What is the current status of trial NCT04323137?
This trial is currently completed. It is a NA study. The enrollment target is 117,649 participants. The study started on 2020-09-21. Estimated completion is 2021-09-21.
What interventions are being tested in trial NCT04323137?
The interventions under investigation include: Risk reduction (BEHAVIORAL), Medical records-based recommendation (BEHAVIORAL), Algorithm-based recommendation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04323137?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04323137's enrollment target sits among peer trials
117,649 2nd of 2000 the highest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06251323 · 119,680 participants · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI